The race to control pain: more participants, more targets

Trends Pharmacol Sci. 1999 Sep;20(9):354-7. doi: 10.1016/s0165-6147(99)01378-4.
No abstract available

MeSH terms

  • Acetates / therapeutic use
  • Amines*
  • Cyclohexanecarboxylic Acids*
  • Excitatory Amino Acid Antagonists / therapeutic use
  • Gabapentin
  • Humans
  • Nicotinic Agonists / therapeutic use
  • Pain / drug therapy*
  • Receptors, Drug / drug effects
  • Sodium Channels / drug effects
  • gamma-Aminobutyric Acid*

Substances

  • Acetates
  • Amines
  • Cyclohexanecarboxylic Acids
  • Excitatory Amino Acid Antagonists
  • Nicotinic Agonists
  • Receptors, Drug
  • Sodium Channels
  • gamma-Aminobutyric Acid
  • Gabapentin